|
US - Mylan Laboratories Inc (MLI) withrew its definitive agreement to acquire all the outstanding common stock of King Pharmaceuticals Inc (KP), a manufacturer and wholesaler of pharmaceuticals, in a stock swap transaction valued at $#.### bil. MLI offered .#…
|
| Credit & Investment Research |
|
|